Conditions: Uveitis
Keywords: uveitis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 59
Healthy volunteers: no

Brief summary:
A 38-week extension to a 24 week multicenter, randomized, double-masked, placebo controlled study to assess the difference in the rate of recurrent exacerbations in Behçet's patients with posterior or panuveitis treated with AIN457 vs placebo adjunctive to standard-of-care immunosuppressive therapy

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None

Interventions: intervention 1: AIN457 intervention 2: AIN457 intervention 3: Placebo AIN457
Intervention descriptions: intervention 1: 300mg every 4 weeks intervention 2: 300mg every 2 weeks intervention 3: Placebo to AIN457

Protocol document: